IGF-1 can specifically induce FASN (fatty acid synthase) to activate the mitogen-activated protein kinase pathway of BC and increase ERα phosphorylation levels, which up-regulated nuclear localization of ERα. The gene discussed is WNK2; the disease is breast cancer.